BACKGROUND: The optimal coronary stenting technique for true left main bifurcation lesions is uncertain. EBC MAIN (European ...

Interv Cardiol. 2012;4(2):245-252. Surgery induces a prothrombotic state, thus predisposing to coronary stent thrombosis. The chance that a patient with coronary artery disease requires noncardiac ...

Late stent thrombosis has been a concern regarding DES use due to a reduction in endothelialization. Randomized trials of DES compared with BMS in de novo coronary lesions have consistently shown ...

Aims Clopidogrel is the most commonly prescribed thienopyridine as part of dual anti-platelet therapy for the treatment of ...

Cardiovascular diseases (CVDs) are a group of conditions that affect the heart and blood vessels, including diseases such as ...

Polymer-free stents show comparable PCI results but with increased early thrombosis risk, impacting clinical choices.

Percutaneous coronary intervention administration of statins enhances ... potentially reducing the risk of myocardial infarction and stent thrombosis by augmenting the endothelial anticoagulant ...

72 The results of the REMEDEE registry further support this technology in the coronary circulation. Of the 1000 patients enrolled over the 5-year study, only 0.9% experienced stent thrombosis, with no ...

Preventing thrombosis and stroke necessitates systemic anticoagulant ... 8 9 The hydrogel has been applied successfully on coronary stents.10 However, coronary and neurointerventional stents have ...

In coronary trials, ticagrelor has a higher bleeding risk than clopidogrel but better platelet inhibition and lower arterial stent restenosis/thrombosis rates. 24,25 Prasugrel has a higher bleeding ...